Supervised learning with word embeddings derived from PubMed captures latent knowledge about protein kinases and cancer

Inhibiting protein kinases (PKs) that cause cancers has been an important topic in cancer therapy for years. So far, almost 8% of >530 PKs have been targeted by FDA-approved medications, and around 150 protein kinase inhibitors (PKIs) have been tested in clinical trials. We present an approach ba...

Full description

Bibliographic Details
Main Authors: Blau, H. (Author), Bocci, G. (Author), Bult, C. (Author), Cappelletti, L. (Author), Carmody, L. (Author), Casiraghi, E. (Author), Coleman, B. (Author), Fontana, T. (Author), George, J. (Author), Hansen, P. (Author), Joachimiak, M. (Author), Mungall, C. (Author), Oprea, T.I (Author), Ravanmehr, V. (Author), Reese, J. (Author), Robinson, P.N (Author), Rueter, J. (Author), Valentini, G. (Author)
Format: Article
Language:English
Published: Oxford University Press 2021
Subjects:
Online Access:View Fulltext in Publisher